This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Traianedes, K. Articles by Bonewald, L. F. Search for Related Content PubMed PubMed Citation Articles by Traianedes, K. Articles by Bonewald, L. F.

5-Lipoxygenase Metabolites Inhibit Bone Formation in Vitro

The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284-7877

Address all correspondence and requests for reprints to: Dr. L. F. Bonewald, Department of Medicine, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78284. E-mail: bonewald{at}uthscsa.edu

The leukotrienes and peptido-leukotrienes are 5-lipoxygenase (5-LO) metabolites of arachidonic acid that appear to have unique effects on bone, distinct from those of the prostaglandins. Application of exogenous leukotrienes in vitro and in vivo results in increased osteoclast formation and bone resorption. While 5-LO metabolites of arachidonic acid clearly stimulate osteoclastic bone resorption, little is known concerning their effects on osteoblastic bone formation. We examined the effects of the 5-LO metabolites 5-HETE, the leukotriene LTB₄ and, as representative of the peptido-leukotrienes, LTD₄ on the formation of mineralized nodules of fetal rat calvarial cells in the presence of dexamethasone and recombinant human bone morphogenetic protein-2 (rhBMP-2). We also examined the effects of these 5-LO metabolites on alkaline phosphatase activity and cell proliferation in these cultures and the effects of 5-HETE and LTB₄ on cultured explants of neonatal murine calvariae. We found that the bone-forming capacity of osteoblasts was impaired when cells were cultured in the presence of 5-LO metabolites. These data indicate that metabolites of the 5-LO pathway are negative regulators of bone formation. The continued presence of these metabolites in the bone environment might account, in part, for the bone loss associated with chronic inflammatory conditions.

This article has been cited by other articles:

				S. Ramanadham, K. E. Yarasheski, M. J. Silva, M. Wohltmann, D. V. Novack, B. Christiansen, X. Tu, S. Zhang, X. Lei, and J. Turk Age-Related Changes in Bone Morphology Are Accelerated in Group VIA Phospholipase A2 (iPLA2{beta})-Null Mice Am. J. Pathol., April 1, 2008; 172(4): 868 - 881. [Abstract] [Full Text] [PDF]

				R. C. Poulsen, P. J. Moughan, and M. C. Kruger Long-Chain Polyunsaturated Fatty Acids and the Regulation of Bone Metabolism Experimental Biology and Medicine, November 1, 2007; 232(10): 1275 - 1288. [Abstract] [Full Text] [PDF]

				C. Fernandez-Tornero, R. M. Lozano, G. Rivas, M. A. Jimenez, L. Standker, D. Diaz-Gonzalez, W.-G. Forssmann, P. Cuevas, A. Romero, and G. Gimenez-Gallego Synthesis of the Blood Circulating C-terminal Fragment of Insulin-like Growth Factor (IGF)-binding Protein-4 in Its Native Conformation: CRYSTALLIZATION, HEPARIN AND IGF BINDING, AND OSTEOGENIC ACTIVITY J. Biol. Chem., May 13, 2005; 280(19): 18899 - 18907. [Abstract] [Full Text] [PDF]

				Y. Mishina, M. W. Starbuck, M. A. Gentile, T. Fukuda, V. Kasparcova, J. G. Seedor, M. C. Hanks, M. Amling, G. J. Pinero, S.-i. Harada, et al. Bone Morphogenetic Protein Type IA Receptor Signaling Regulates Postnatal Osteoblast Function and Bone Remodeling J. Biol. Chem., June 25, 2004; 279(26): 27560 - 27566. [Abstract] [Full Text] [PDF]

				Z. Liu, W. Shi, X. Ji, C. Sun, W. S. S. Jee, Y. Wu, Z. Mao, T. R. Nagy, Q. Li, and X. Cao Molecules Mimicking Smad1 Interacting with Hox Stimulate Bone Formation J. Biol. Chem., March 19, 2004; 279(12): 11313 - 11319. [Abstract] [Full Text] [PDF]

				R. F. Klein, J. Allard, Z. Avnur, T. Nikolcheva, D. Rotstein, A. S. Carlos, M. Shea, R. V. Waters, J. K. Belknap, G. Peltz, et al. Regulation of Bone Mass in Mice by the Lipoxygenase Gene Alox15 Science, January 9, 2004; 303(5655): 229 - 232. [Abstract] [Full Text] [PDF]

				M. Zhao, S. E. Harris, D. Horn, Z. Geng, R. Nishimura, G. R. Mundy, and Di Chen Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation J. Cell Biol., June 10, 2002; 157(6): 1049 - 1060. [Abstract] [Full Text] [PDF]

				B. Yi, P. J. Williams, M. Niewolna, Y. Wang, and T. Yoneda Tumor-derived Platelet-derived Growth Factor-BB Plays a Critical Role in Osteosclerotic Bone Metastasis in an Animal Model of Human Breast Cancer Cancer Res., February 1, 2002; 62(3): 917 - 923. [Abstract] [Full Text] [PDF]

				B. A. Watkins, Y. Li, H. E. Lippman, and M. F. Seifert Omega-3 Polyunsaturated Fatty Acids and Skeletal Health Experimental Biology and Medicine, June 1, 2001; 226(6): 485 - 497. [Abstract] [Full Text] [PDF]

				H. Mano, C. Kimura, Y. Fujisawa, T. Kameda, M. Watanabe-Mano, H. Kaneko, T. Kaneda, Y. Hakeda, and M. Kumegawa Cloning and Function of Rabbit Peroxisome Proliferator-activated Receptor delta /beta in Mature Osteoclasts J. Biol. Chem., March 10, 2000; 275(11): 8126 - 8132. [Abstract] [Full Text] [PDF]

				G. Mundy, R. Garrett, S. Harris, J. Chan, D. Chen, G. Rossini, B. Boyce, M. Zhao, and G. Gutierrez Stimulation of Bone Formation in Vitro and in Rodents by Statins Science, December 3, 1999; 286(5446): 1946 - 1949. [Abstract] [Full Text]